PART I Business Overview The Company, headquartered in Cranford, New Jersey, is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. The Companys strategy centers on achieving a market leading position by advancing innovative therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs w...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-23 | 2025-09-30 | 0001213900-25-125331 | EDGAR | 61K words |
| 2024-12-27 | 2024-09-30 | 0001213900-24-113150 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014850 | EDGAR | — |
| 2023-04-17 | 2022-12-31 | 0001493152-23-012545 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001213900-26-015877 | EDGAR | 15K words |
| 2025-08-12 | 2025-06-30 | 0001213900-25-074992 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001213900-25-043359 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001213900-25-014320 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030991 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020783 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001493152-23-042170 | EDGAR | — |
| 2023-08-16 | 2023-06-30 | 0001493152-23-029131 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017394 | EDGAR | — |
| 2022-11-28 | 2022-09-30 | 0001493152-22-033847 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001213900-26-085434 | EDGAR | — |
| 2026-03-31 | 0001213900-26-037501 | EDGAR | 3K words |
| 2026-03-10 | 0001213900-26-025464 | EDGAR | — |
| 2026-03-04 | 0001213900-26-023440 | EDGAR | — |
| 2026-02-13 | 0001213900-26-015894 | EDGAR | — |
| 2025-12-23 | 0001213900-25-125418 | EDGAR | — |
| 2025-12-10 | 0001213900-25-120197 | EDGAR | — |
| 2025-12-01 | 0001213900-25-116764 | EDGAR | — |
| 2025-10-27 | 0001213900-25-102625 | EDGAR | — |
| 2025-10-23 | 0001213900-25-101737 | EDGAR | — |
76 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001851484 |
| Ticker | CTOR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.citiusonc.com |
| Listed | 2024-08-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CTOR (~200 tokens, structured JSON with cryptographic provenance)